All changes for the tissue nervous system (767)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA153
neurexin 1
Molecular
brain
Human
NRXN1
15.0% Decrease Gene Expression Level
DAA148
neurocalcin delta
Molecular
brain
Human
NCALD
9.0% Decrease Gene Expression Level
DAA721
Neurofibrillary tangles and Lewy bodies in neurons
Physiological
brain
Human
—
—
DAA1948
Neurogenesis is reduced
Physiological
brain
Mouse
—
—
DAA152
neurogranin (protein kinase C substrate, RC3)
Molecular
brain
Human
NRGN
4.0% Decrease Gene Expression Level
DAA714
Neuronal soma shrinks in size
Physiological
brain
Human
—
—
DAA1418
neuropeptide Y
Molecular
hippocampus
Mouse
Npy
3.0% Increase Gene Expression Level
DAA1268
neuropilin 1
Molecular
brain
Mouse
Nrp1
5.0% Decrease Gene Expression Level
DAA155
neurotensin receptor 2
Molecular
brain
Human
NTSR2
7.0% Increase Gene Expression Level
DAA733
Neurotransmitter and neuro receptor concentrations are altered
Physiological
brain
Human
—
—
DAA150
NIMA (never in mitosis gene a)-related kinase 7
Molecular
brain
Human
NEK7
17.0% Increase Gene Expression Level
DAA151
NK2 homeobox 2
Molecular
brain
Human
NKX2-2
14.0% Increase Gene Expression Level
DAA2249
NLR family, pyrin domain containing 1 decreases with age
Molecular
frontal lobe
Human
NLRP1
29.4% Decrease Gene Expression Level
DAA2265
NLR family, pyrin domain containing 1 decreases with age
Molecular
parietal lobe
Human
NLRP1
24.8% Decrease Gene Expression Level
DAA1938
No clear changes in anxiety but decrease in ambulation
Psychological
brain
Mouse
—
—
DAA149
Norrie disease (pseudoglioma)
Molecular
brain
Human
NDP
9.0% Increase Gene Expression Level
DAA157
nuclear fragile X mental retardation protein interacting protein 1
Molecular
brain
Human
NUFIP1
24.0% Decrease Gene Expression Level
DAA158
nuclear transport factor 2-like export factor 2
Molecular
brain
Human
NXT2
22.0% Increase Gene Expression Level
DAA156
nudix (nucleoside diphosphate linked moiety X)-type motif 21
Molecular
brain
Human
NUDT21
28.0% Decrease Gene Expression Level
DAA160
olfactomedin 1
Molecular
brain
Human
OLFM1
5.0% Decrease Gene Expression Level
DAA162
olfactory receptor, family 2, subfamily H, member 2
Molecular
brain
Human
OR2H2
16.0% Decrease Gene Expression Level
DAA161
oligodendrocyte lineage transcription factor 2
Molecular
brain
Human
OLIG2
12.0% Increase Gene Expression Level
DAA1419
oncostatin M receptor
Molecular
hippocampus
Mouse
Osmr
9.0% Increase Gene Expression Level
DAA159
ornithine decarboxylase antizyme 1
Molecular
brain
Human
OAZ1
4.0% Decrease Gene Expression Level
DAA164
osteoclast stimulating factor 1
Molecular
brain
Human
OSTF1
29.0% Decrease Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA153 | neurexin 1 | Molecular | brain | Human | NRXN1 | 15.0% Decrease Gene Expression Level | |
DAA148 | neurocalcin delta | Molecular | brain | Human | NCALD | 9.0% Decrease Gene Expression Level | |
DAA721 | Neurofibrillary tangles and Lewy bodies in neurons | Physiological | brain | Human | — | — | |
DAA1948 | Neurogenesis is reduced | Physiological | brain | Mouse | — | — | |
DAA152 | neurogranin (protein kinase C substrate, RC3) | Molecular | brain | Human | NRGN | 4.0% Decrease Gene Expression Level | |
DAA714 | Neuronal soma shrinks in size | Physiological | brain | Human | — | — | |
DAA1418 | neuropeptide Y | Molecular | hippocampus | Mouse | Npy | 3.0% Increase Gene Expression Level | |
DAA1268 | neuropilin 1 | Molecular | brain | Mouse | Nrp1 | 5.0% Decrease Gene Expression Level | |
DAA155 | neurotensin receptor 2 | Molecular | brain | Human | NTSR2 | 7.0% Increase Gene Expression Level | |
DAA733 | Neurotransmitter and neuro receptor concentrations are altered | Physiological | brain | Human | — | — | |
DAA150 | NIMA (never in mitosis gene a)-related kinase 7 | Molecular | brain | Human | NEK7 | 17.0% Increase Gene Expression Level | |
DAA151 | NK2 homeobox 2 | Molecular | brain | Human | NKX2-2 | 14.0% Increase Gene Expression Level | |
DAA2249 | NLR family, pyrin domain containing 1 decreases with age | Molecular | frontal lobe | Human | NLRP1 | 29.4% Decrease Gene Expression Level | |
DAA2265 | NLR family, pyrin domain containing 1 decreases with age | Molecular | parietal lobe | Human | NLRP1 | 24.8% Decrease Gene Expression Level | |
DAA1938 | No clear changes in anxiety but decrease in ambulation | Psychological | brain | Mouse | — | — | |
DAA149 | Norrie disease (pseudoglioma) | Molecular | brain | Human | NDP | 9.0% Increase Gene Expression Level | |
DAA157 | nuclear fragile X mental retardation protein interacting protein 1 | Molecular | brain | Human | NUFIP1 | 24.0% Decrease Gene Expression Level | |
DAA158 | nuclear transport factor 2-like export factor 2 | Molecular | brain | Human | NXT2 | 22.0% Increase Gene Expression Level | |
DAA156 | nudix (nucleoside diphosphate linked moiety X)-type motif 21 | Molecular | brain | Human | NUDT21 | 28.0% Decrease Gene Expression Level | |
DAA160 | olfactomedin 1 | Molecular | brain | Human | OLFM1 | 5.0% Decrease Gene Expression Level | |
DAA162 | olfactory receptor, family 2, subfamily H, member 2 | Molecular | brain | Human | OR2H2 | 16.0% Decrease Gene Expression Level | |
DAA161 | oligodendrocyte lineage transcription factor 2 | Molecular | brain | Human | OLIG2 | 12.0% Increase Gene Expression Level | |
DAA1419 | oncostatin M receptor | Molecular | hippocampus | Mouse | Osmr | 9.0% Increase Gene Expression Level | |
DAA159 | ornithine decarboxylase antizyme 1 | Molecular | brain | Human | OAZ1 | 4.0% Decrease Gene Expression Level | |
DAA164 | osteoclast stimulating factor 1 | Molecular | brain | Human | OSTF1 | 29.0% Decrease Gene Expression Level |